ATLANTA, June 07, 2017 (GLOBE NEWSWIRE) -- Vystar Corp. (OTC:VYST) has received a notice of allowance from Indonesia for a patent regarding “Natural Rubber Latex Having Reduced Allergenicity and Method of Making Same.” Vystar now holds 11 international and four domestic patents related to its latex deproteinization process which results in Vytex ® , a natural rubber latex (NRL) virtually free of allergen-causing latex proteins, thereby reducing risk of developing or experiencing allergic reactions from direct contact.
“This notice of allowance provides important intellectual property (IP) protection for Vystar as we actively work with latex producers and manufacturers in Indonesia and seek to develop relationships with additional ones, particularly medical glove manufacturers to meet the growing demand for low protein, non-powdered, medical gloves,” stated William Doyle, CEO of Vystar.
Vystar now has IP protection in Indonesia, Malaysia and India, which are three of the world’s top five producers of natural rubber, with Malaysia ranking first in latex glove production. The latex industry is estimated at approximately US$1.3 billion.
Latex allergies and powdered gloves have become a major concern in the healthcare industry, with some facilities banning latex gloves and the US recently banning powdered gloves. However, surgeons and medical professionals prefer latex over synthetic latex, vinyl and other materials due to its superior tactile sensitivity, puncture resistance, strength, durability and flexibility. This presents a tremendous market opportunity for Vytex medical gloves as they are virtually free of allergy-causing proteins while providing all the benefits of latex that healthcare workers want, and they don’t need powder to ease glove donning and removal.
Additionally, Vytex is sustainably sourced and completely biodegradable, in sharp contrast to petrochemical based synthetic latex or petrochemical based disposable gloves. Plus, those who need to wear disposable gloves appreciate that Vytex is virtually odor-free, without the strong odor of traditional latex. The Vytex deproteinization process also removes the source of the latex odor, making Vytex more eco friendly than its competitors as there is no need for the excessive water rinses to remove odor during the manufacturing process or the need for artificial fragrance to mask the odor.
Competitively priced against traditional latex, Vytex is a superior material for more than 40,000 applications that typically use latex or petrochemical based materials. Vytex can be used in medical gloves, catheters and devices; condoms; mattresses, toppers and pillows; cushions; balloons; adhesives; sports equipment, footwear; padding, apparel and threads.
For details on Vytex licensing, deproteinization or purchase, contact info@vytex.com or (866) 674-5238, x1 or visit Vytex.com.
About Vystar Corporation Based in Atlanta, GA, Vystar® Corporation (OTC:VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, balloons, condoms, medical devices, mattresses, toppers, and pillows. For more information, visit www.vytex.com .
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
Contacts: Vystar - Media: Julie Shepherd, Accentuate PR, 847 275 3643, Julie@accentuatepr.com Vystar -Investors: William Doyle, President (866) 674-5238, x1
